Drug
Anavex2 73 Liquid
Anavex2 73 Liquid: highest development phase Phase 2/3, developed by Anavex Life Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Anavex Life Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| ANAVEX2-73 oral liquid NCT04304482 | Phase 2/3 | Rett Syndrome |
Latest
No recent events.
Follow Anavex2 73 Liquid on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.